What Happened?
Boston, MA-based Medisafe Appointed Rotem Shor as Co founder and Chief Technology Officer
About the Company
Medisafe® is the leading Personalized Medication Management Platform helping patients stay on top of all their medications. Way more than a pill organizer (although it`s that, too), Medisafe makes it easy to adhere to the most complicated medication schedule, so wondering, “Did I take this already?” is a thing of the past. But that`s just the beginning. Medisafe connects users to their family (and soon, their doctors) for support, encouragement and expertise. It learns about each user`s unique situation, so it can deliver custom notifications for appointments and refills, medication updates, personalized health recommendations and discounts to help you stay organized, informed and on budget. And it tracks progress correlated with measurements like blood pressure and glucose levels to show the direct health benefit of taking meds as prescribed. By addressing all the major root causes for failing to take medications as prescribed, Medisafe improves patient satisfaction and quality of care and eliminates admissions and outpatient visits resulting from incorrect or missed doses. Medisafe arms providers and payers with information about patient compliance and related behaviors, so they can focus on the most pressing situations at any time. Understanding which patients are most at risk (and threatening to add avoidable strain to an overburdened healthcare system) helps all stakeholders in the care continuum use limited time and resources as efficiently as possible. Medisafe currently has more than 7 million users across iOS and Android smartphones and tablets, who have recorded over 4 billion medication doses taken correctly. Nearly 250,000 users have rated the app an average of 4.6 out of 5 stars in the iTunes and Google Play app stores.
About the Person
Rotem Shor is Co founder and Chief Technology Officer at Medisafe. Previously, Rotem held various senior HR leadership roles in the industry.
Info Source
News
Short Profile